228 related articles for article (PubMed ID: 15206669)
1. Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene.
Eap CB; Bender S; Jaquenoud Sirot E; Cucchia G; Jonzier-Perey M; Baumann P; Allorge D; Broly F
J Clin Psychopharmacol; 2004 Apr; 24(2):214-9. PubMed ID: 15206669
[TBL] [Abstract][Full Text] [Related]
2. Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.
Bondolfi G; Morel F; Crettol S; Rachid F; Baumann P; Eap CB
Ther Drug Monit; 2005 Aug; 27(4):539-43. PubMed ID: 16044115
[TBL] [Abstract][Full Text] [Related]
3. Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.
Ozdemir V; Kalow W; Okey AB; Lam MS; Albers LJ; Reist C; Fourie J; Posner P; Collins EJ; Roy R
J Clin Psychopharmacol; 2001 Dec; 21(6):603-7. PubMed ID: 11763009
[TBL] [Abstract][Full Text] [Related]
4. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement.
van der Weide J; Steijns LS; van Weelden MJ
Pharmacogenetics; 2003 Mar; 13(3):169-72. PubMed ID: 12618594
[TBL] [Abstract][Full Text] [Related]
5. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
6. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
[TBL] [Abstract][Full Text] [Related]
7. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
Jaquenoud Sirot E; Knezevic B; Morena GP; Harenberg S; Oneda B; Crettol S; Ansermot N; Baumann P; Eap CB
J Clin Psychopharmacol; 2009 Aug; 29(4):319-26. PubMed ID: 19593168
[TBL] [Abstract][Full Text] [Related]
8. Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity.
Lesche D; Mostafa S; Everall I; Pantelis C; Bousman CA
Pharmacogenomics J; 2020 Apr; 20(2):192-201. PubMed ID: 31616047
[TBL] [Abstract][Full Text] [Related]
9. The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
Kootstra-Ros JE; Smallegoor W; van der Weide J
Ann Clin Biochem; 2005 May; 42(Pt 3):216-9. PubMed ID: 15949157
[TBL] [Abstract][Full Text] [Related]
10. Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine.
Carrillo JA; Herráiz AG; Ramos SI; Gervasini G; Vizcaíno S; Benítez J
J Clin Psychopharmacol; 2003 Apr; 23(2):119-27. PubMed ID: 12640212
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel splice-site mutation in the CYP1A2 gene.
Allorge D; Chevalier D; Lo-Guidice JM; Cauffiez C; Suard F; Baumann P; Eap CB; Broly F
Br J Clin Pharmacol; 2003 Sep; 56(3):341-4. PubMed ID: 12919186
[TBL] [Abstract][Full Text] [Related]
12. [Switching to e-cigarettes affects drug concentration].
Berm EJ; Ruijsbroek R; Loonen AJ; Goethals KR; Wilffert B; van Hasselt F
Ned Tijdschr Geneeskd; 2015; 159():A9090. PubMed ID: 26200424
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole reduces clozapine plasma concentrations. A case report.
Frick A; Kopitz J; Bergemann N
Pharmacopsychiatry; 2003 May; 36(3):121-3. PubMed ID: 12806570
[TBL] [Abstract][Full Text] [Related]
14. Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.
Tóth K; Csukly G; Sirok D; Belic A; Kiss Á; Háfra E; Déri M; Menus Á; Bitter I; Monostory K
Int J Neuropsychopharmacol; 2017 Jul; 20(7):529-537. PubMed ID: 28340122
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking has a differential effect on the plasma level of clozapine in Taiwanese schizophrenic patients associated with the CYP1A2 gene -163A/C single nucleotide polymorphism.
Huang HC; Lua AC; Wu LS; Wu BJ; Lee SM; Liu CZ
Psychiatr Genet; 2016 Aug; 26(4):172-7. PubMed ID: 27203225
[TBL] [Abstract][Full Text] [Related]
16. CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine.
Viikki M; Kampman O; Seppälä N; Mononen N; Lehtimäki T; Leinonen E
BMC Psychiatry; 2014 Feb; 14():50. PubMed ID: 24555493
[TBL] [Abstract][Full Text] [Related]
17. Utilizing plasma drug levels and genetic testing to achieve optimal treatment response in a patient with treatment-resistant schizoaffective disorder.
Xu JJ; Xiao C; Pan Y; Tang YL; Wang M; Li S; Xie G; Du J; Ren Y; Wang W
Bipolar Disord; 2024 Feb; 26(1):95-97. PubMed ID: 38097824
[TBL] [Abstract][Full Text] [Related]
18. Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.
Sachse C; Brockmöller J; Bauer S; Roots I
Br J Clin Pharmacol; 1999 Apr; 47(4):445-9. PubMed ID: 10233211
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.
Ammar H; Chadli Z; Mhalla A; Khouadja S; Hannachi I; Alshaikheid M; Slama A; Ben Fredj N; Ben Fadhel N; Ben Romdhane H; Chaabane A; Boughattas NA; Gaha L; Zarrouk L; Aouam K
Pharmacogenomics J; 2021 Oct; 21(5):551-558. PubMed ID: 33731885
[TBL] [Abstract][Full Text] [Related]
20. Correlation between assessment of cytochrome P450 1A2 activity and enzyme activity scores, and their relation to clozapine exposure.
Alarcan H; Cannet P; Camus V; Fond G; Zendjidjian X; Guilhaumou R; Quaranta S
Br J Clin Pharmacol; 2023 May; 89(5):1665-1671. PubMed ID: 36507652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
